As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec ... for Alzheimer Disease Dec. 5, 2024 — New research has found that women who have had both ovaries ...